GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 632 filers reported holding GLAXOSMITHKLINE PLC in Q3 2013. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $110,000 | +10.0% | 2,344 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $100,000 | -20.0% | 2,344 | -24.9% | 0.00% | 0.0% |
| Q2 2019 | $125,000 | +13.6% | 3,121 | +14.7% | 0.00% | 0.0% |
| Q3 2017 | $110,000 | -8.3% | 2,720 | -2.0% | 0.00% | 0.0% |
| Q2 2017 | $120,000 | -3.2% | 2,775 | -5.9% | 0.00% | 0.0% |
| Q1 2017 | $124,000 | +26.5% | 2,950 | +15.7% | 0.00% | 0.0% |
| Q4 2016 | $98,000 | -10.9% | 2,550 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $110,000 | -98.8% | 2,550 | -98.7% | 0.00% | -98.6% |
| Q1 2015 | $9,340,000 | +19.4% | 202,394 | +10.6% | 0.07% | +18.3% |
| Q4 2014 | $7,820,000 | -13.8% | 182,970 | -7.2% | 0.06% | -15.5% |
| Q3 2014 | $9,068,000 | -91.3% | 197,267 | -89.9% | 0.07% | -90.8% |
| Q2 2014 | $104,471,000 | -2.4% | 1,953,470 | -2.5% | 0.77% | -6.7% |
| Q1 2014 | $107,086,000 | -6.7% | 2,004,231 | -6.7% | 0.82% | -6.5% |
| Q4 2013 | $114,734,000 | +2347.4% | 2,148,983 | +2199.6% | 0.88% | +2102.5% |
| Q3 2013 | $4,688,000 | -2.1% | 93,450 | -2.5% | 0.04% | -4.8% |
| Q2 2013 | $4,790,000 | – | 95,850 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |